Evidence map›Paper›PMID 36100952›Full record

ArticleGenome biology2022

Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.

Michelle S Kim, Daphne Naidoo, Ujani Hazra, Melanie H Quiver, Wenlong C Chen, Corinne N Simonti, Paidamoyo Kachambwa, Maxine Harlemon, Ilir Agalliu, Shakuntala Baichoo and 38 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Geneticization of Education and Its Bioethical Implications.Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Imputation accuracy across global human populations.American journal of human genetics · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  19. Imputation Accuracy Across Global Human Populations.bioRxiv : the preprint server for biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 18 institutions in 6 countries.

Michelle S KimSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA.
Daphne NaidooCentre for Proteomic and Genomic Research, Cape Town, South Africa.
Ujani HazraSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA.
Melanie H QuiverSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA.
Wenlong C ChenSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Corinne N SimontiSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA.
Paidamoyo KachambwaCentre for Proteomic and Genomic Research, Cape Town, South Africa.
Maxine HarlemonSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA.
Ilir AgalliuDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Shakuntala BaichooUniversity of Mauritius, Réduit, Mauritius.
Pedro FernandezFaculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ann W HsingStanford Cancer Institute, Stanford University, Stanford, CA, USA.
Mohamed JallohUniversite Cheikh Anta Diop de Dakar, Dakar, Senegal.
Serigne M GueyeUniversite Cheikh Anta Diop de Dakar, Dakar, Senegal.
Lamine NiangUniversite Cheikh Anta Diop de Dakar, Dakar, Senegal.
Halimatou DiopUniversite Cheikh Anta Diop de Dakar, Dakar, Senegal.
Medina NdoyeUniversite Cheikh Anta Diop de Dakar, Dakar, Senegal.
Nana Yaa Snyper37 Military Hospital, Accra, Ghana.
Ben Adusei37 Military Hospital, Accra, Ghana.
James E MensahKorle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana.
Afua O D AbrahamsKorle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana.
Richard BiritwumKorle-Bu Teaching Hospital and University of Ghana Medical School, Accra, Ghana.
Andrew A AdjeiDepartment of Pathology, University of Ghana Medical School, Accra, Ghana.
Akindele O AdebiyiCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Olayiwola ShittuCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Olufemi OgunbiyiCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Sikiru AdebayoCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Oseremen I Aisuodionoe-ShadrachCollege of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Abuja, Nigeria.
Maxwell M NwegbuCollege of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Abuja, Nigeria.
Hafees O AjibolaCollege of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Abuja, Nigeria.
Olabode P OluwoleCollege of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Abuja, Nigeria.
Mustapha A JamdaCollege of Health Sciences, University of Abuja and University of Abuja Teaching Hospital, Abuja, Nigeria.
Elvira SinghNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Audrey PentzNon-Communicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.
Maureen JoffeNon-Communicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.
Burcu F DarstKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
David V ContiKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Christopher A HaimanKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Petrus V SpiesFaculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
André van der MerweFaculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Judith JacobsonHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
Alfred I NeugutHerbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
Jo McBrideCentre for Proteomic and Genomic Research, Cape Town, South Africa.
Caroline AndrewsDana-Farber Cancer Institute, Boston, MA, USA.
Lindsay N PetersenCentre for Proteomic and Genomic Research, Cape Town, South Africa.
Timothy R RebbeckDana-Farber Cancer Institute, Boston, MA, USA.
Joseph LachanceSchool of Biological Sciences, Georgia Institute of Technology, 950 Atlantic Dr, Atlanta, GA, 30332, USA. joseph.lachance@biology.gatech.edu.ORCID 0000-0002-4650-3741
Georgia Institute of Technology · USCheikh Anta Diop University · SNUniversity of Abuja Teaching Hospital · NGAfrican Organisation for Research and Training in Cancer · ZAUniversity of Ghana · GHUniversity of Ibadan · NGStellenbosch University · ZAUniversity of Southern California · US37 Military Hospital · GHAlbert Einstein College of Medicine · USColumbia University Irving Medical Center · USNational Health Laboratory Service · ZAAfrica Health Research Institute · ZADana-Farber Cancer Institute · USHarvard University · USStanford University · USUniversity of Mauritius · MUUniversity of the Witwatersrand · ZA

Funding

Nutritional Assessment of Cancer Risk in African MenU01CA184374 · NCI · DANA-FARBER CANCER INST · PI REBBECK, TIMOTHY R · 2015 to 2019
$9.1M
Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk ScoresU01CA261339 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fei Chen, David V Conti · 2021 to 2026
$5.2M
Evolution of genetic disease risks over time and spaceR35GM133727 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI LACHANCE, JOSEPH L. · 2019 to 2023
$1.9M
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NCI NIH HHS U01 CA184374NCI NIH HHS U01 CA261339NIGMS NIH HHS R35 GM133727
6 · The paper itself

Abstract

backgroundGenome-wide association studies do not always replicate well across populations, limiting the generalizability of polygenic risk scores (PRS). Despite higher incidence and mortality rates of prostate cancer in men of African descent, much of what is known about cancer genetics comes from populations of European descent. To understand how well genetic predictions perform in different populations, we evaluated test characteristics of PRS from three previous studies using data from the UK Biobank and a novel dataset of 1298 prostate cancer cases and 1333 controls from Ghana, Nigeria, Senegal, and South Africa.

resultsAllele frequency differences cause predicted risks of prostate cancer to vary across populations. However, natural selection is not the primary driver of these differences. Comparing continental datasets, we find that polygenic predictions of case vs. control status are more effective for European individuals (AUC 0.608-0.707, OR 2.37-5.71) than for African individuals (AUC 0.502-0.585, OR 0.95-2.01). Furthermore, PRS that leverage information from African Americans yield modest AUC and odds ratio improvements for sub-Saharan African individuals. These improvements were larger for West Africans than for South Africans. Finally, we find that existing PRS are largely unable to predict whether African individuals develop aggressive forms of prostate cancer, as specified by higher tumor stages or Gleason scores.

conclusionsGenetic predictions of prostate cancer perform poorly if the study sample does not match the ancestry of the original GWAS. PRS built from European GWAS may be inadequate for application in non-European populations and perpetuate existing health disparities.

Indexed as

Genome-Wide Association StudyProstatic NeoplasmsAfrica South of the SaharaGenetic Predisposition to DiseaseHumansMaleRisk FactorsAfricaGenomic medicineHealth disparitiesPolygenic risk scoresPopulation geneticsProstate cancer

Identifiers

PMID36100952
PMCPMC9472407
OpenAlexW4295358343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.